Nicotinamide Adenine Dinucleotide Supplementation in Parkinson's Disease: A Potential Disease-Modifying Agent Targeting Multiple Pathways

被引：1
|
作者：
Martinez-Villota, Viviana Alexandra [1 ]
Rossi, Malco [1 ,2 ]
Castillo-Torres, Sergio A. [1 ]
机构：
[1] Serv Movimientos Anorm, Dept Neurol, Montaneses 2325,C1428AQK, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina
来源：
MOVEMENT DISORDERS CLINICAL PRACTICE | 2022年 / 9卷 / 06期
关键词：
Parkinson's disease; clinical trial; neuroprotection; NAD;
D O I：
10.1002/mdc3.13500
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：735 / 736
页数：2
相关论文
共 50 条
  • [1] Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors
    Makoto Naoi
    Wakako Maruyama
    Masayo Shamoto-Nagai
    Journal of Neural Transmission, 2022, 129 : 737 - 753
  • [2] Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors
    Naoi, Makoto
    Maruyama, Wakako
    Shamoto-Nagai, Masayo
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) : 737 - 753
  • [3] The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
    Lauterbach, Edward C.
    Fontenelle, Leonardo F.
    Teixeira, Antonio L.
    PARKINSONS DISEASE, 2012, 2012
  • [4] Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease
    Morales-Briceno, Hugo
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2020, 35 (01) : 81 - 81
  • [5] Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease
    O'Hara, Darren M.
    Kalia, Suneil K.
    Kalia, Lorraine V.
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (15) : 3080 - 3089
  • [6] Disease-Modifying Drugs in Parkinson’s Disease
    Ariane Park
    Mark Stacy
    Drugs, 2015, 75 : 2065 - 2071
  • [7] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [8] Disease-Modifying Drugs in Parkinson's Disease
    Park, Ariane
    Stacy, Mark
    DRUGS, 2015, 75 (18) : 2065 - 2071
  • [9] Disease-Modifying Strategies for Parkinson's Disease
    Kalia, Lorraine V.
    Kalia, Suneil K.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2015, 30 (11) : 1442 - 1450
  • [10] MANF: a new potential disease-modifying drug candidate for Parkinson's disease
    Commissiong, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S109 - S109
12345